Defton-T 1.125 Injection
Marketer
Clabert Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Tazobactum (125mg)
Overview Defton-T 1.125 Injection
Defton-T 1.125 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby limiting infection spread. Administration must be solely by a healthcare provider. Consistent adherence to the prescribed schedule is vital; complete the entire course, regardless of symptom improvement. Premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms immediately to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol should be avoided due to potential additive drowsiness. While driving ability is generally unaffected, refrain from driving if drowsiness or dizziness occur. Adequate rest, nutritious food, and sufficient hydration facilitate recovery. Your physician may order tests to monitor the medicine's impact.
Primary Ingredients of Defton-T 1.125 Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Defton-T 1.125 Injection
Infections caused by bacteria
Major Benefits of Defton-T 1.125 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Defton-T 1.125 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Defton-T 1.125 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Defton-T 1.125 Injection works:
Defton-T 1.125 Injection combines Ceftriaxone, a bacterial growth inhibitor, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, thus hindering bacterial survival. Tazobactum counteracts bacterial resistance mechanisms, optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Defton-T 1.125 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Defton-T 1.125 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Defton-T 1.125 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Defton-T 1.125 Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Defton-T 1.125 Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Defton-T 1.125 Injection to individuals with severe hepatic impairment requires careful consideration and potential dose modification. Patients with mild to moderate liver disease do not typically require Defton-T 1.125 Injection dose adjustments. Physician consultation is advised.
What if you forget to take Defton-T 1.125 Injection :
Omit a Defton-T 1.125 Injection dose? Seek medical advice immediately.
Facts to Know About Defton-T 1.125 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently